Eczema Free Forever™

Buoyed by new eczema data, AnaptysBio hits the fundraising button – FierceBiotech


FierceBiotech
Buoyed by new eczema data, AnaptysBio hits the fundraising button
FierceBiotech
After a single dose of ANB020, 75% of the 12 enrolled patients achieved an Eczema Area Severity Index score improvement of 50% (EASI-50) or more at day 15, 83% of patients at day 29 and 75% of patients achieved EASI-50 after 57 days or around two …
AnaptysBio Could Rival Regeneron Pharmaceuticals, Sanofi In …Investor’s Business Daily
Here's Why AnaptysBio Inc. Is Rocketing Higher TodayMadison.com
AnaptysBio has game-changing results in atopic dermatitisBioPharma Dive
Financialbuzz.com –Market Exclusive –Clinical Leader
all 70 news articles »

eczema – Google News

Eczema Free Forever™